Zymeworks (ZYME) Leases (2021 - 2026)
Zymeworks recorded quarterly Leases of $14.0 million in Q1 2026, down 10.86% quarter-over-quarter from $15.7 million in Q4 2025, and down 16.19% year-over-year from $16.7 million in Q1 2025.
Zymeworks' Leases history runs 6 years deep, the most recent figure standing at $14.0 million for Q1 2026.
- In Q1 2026, Leases fell 16.19% year-over-year to $14.0 million; the TTM figure through Mar 2026 stood at $14.0 million (down 16.19% YoY), while the FY2025 annual figure was $15.7 million, down 5.65% from the prior year.
- Leases came in at $14.0 million for Q1 2026 at Zymeworks, down from $15.7 million in the prior quarter.
- In the past five years, Leases ranged from a high of $23.6 million in Q3 2022 to a low of $14.0 million in Q1 2026.
- A 5-year average of $18.2 million and a median of $17.3 million in 2024 frame the typical range for Leases.
- Across the five-year window, Leases decreased 24.22% in 2023 and dropped 2.02% in 2025, its largest moves.
- Zymeworks' Leases stood at $22.9 million in 2022, then retreated by 22.85% to $17.7 million in 2023, then slipped by 5.82% to $16.7 million in 2024, then fell by 5.65% to $15.7 million in 2025, then retreated by 10.86% to $14.0 million in 2026.
- According to Business Quant data, Leases over the past three periods registered $14.0 million, $15.7 million, and $16.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - | 14.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.02 Mn |
| Dec 31, 2025 | 15.72 Mn |
| Sep 30, 2025 | 16.65 Mn |
| Jun 30, 2025 | 16.26 Mn |
| Mar 31, 2025 | 16.72 Mn |
| Dec 31, 2024 | 16.67 Mn |
| Sep 30, 2024 | 17.36 Mn |
| Jun 30, 2024 | 17.28 Mn |
| Mar 31, 2024 | 17.07 Mn |
| Dec 31, 2023 | 17.70 Mn |
| Sep 30, 2023 | 17.86 Mn |
| Jun 30, 2023 | 20.80 Mn |
| Mar 31, 2023 | 22.30 Mn |
| Dec 31, 2022 | 22.94 Mn |
| Sep 30, 2022 | 23.56 Mn |
| Dec 31, 2021 | 26.99 Mn |